Effect of challenging neck anatomy on mid-term migration rates in AneuRx endografts  by Fulton, Joseph J. et al.
From the Midwestern Vascular Surgical Society
Effect of challenging neck anatomy on mid-term
migration rates in AneuRx endografts
Joseph J. Fulton, MD,a Mark A. Farber, MD,a Luis A. Sanchez, MD,b Christopher J. Godshall, MD,b
William A. Marston, MD,a Robert Mendes, MD,a Brian G. Rubin, MD,b Gregorio A. Sicard, MD,b
and Blair A. Keagy, MD,a Chapel Hill, NC; and St Louis, Mo
Objective: To establish the effect of challenging neck anatomy on the mid- and long-term incidence of migration with the
AneuRx bifurcated device in patients treated after Food and Drug Administration approval and to identify the predictive
factors for device migration.
Methods: Prospectively maintained databases at the University of North Carolina (UNC) and Washington University
(WU) were used to identify 595 patients (UNC, n  230; WU, n  365) who underwent endovascular repair of an
infrarenal abdominal aortic aneurysm with the AneuRx bifurcated stent graft. Those patients with at least 30 months of
follow-up were identified and underwent further assessment of migration (UNC, n  25; WU, n  59) by use of
multiplanar reconstructed computed tomographic scans.
Results: Eighty-four patients with a mean follow-up time of 40.3 months (range, 30-55 months) were studied. Seventy
percent of the patients (n  59) met all inclusion criteria for neck anatomy (length, angle, diameter, and quality) as
defined by the revised instructions for use guidelines and are referred to as those with favorable neck anatomy (FNA).
The remaining 25 patients retrospectively fell outside of the revised instructions for use guidelines and are referred
to as those with unfavorable neck anatomy (UFNA). Life-table analysis for FNA patients at 2 and 4 years revealed a
migration rate of 0% and 6.1%, respectively. For UFNA patients, it was 24.0% and 42.1% at 2 and 4 years, respectively
(P< .0001). The overall (FNA andUFNA)migration rate was 7.1% and 17.1% at 2 and 4 years, respectively. Overall, late
graft-related complications occurred in 38% of patients (FNA, 27%; UFNA, 64%; P .003; relative risk, 1.7). There was
no incidence of late rupture or open conversion. The relative risk of migration for UFNA patients was 2.5 compared with
FNA patients (P  .0003). A larger neck angle and a longer initial graft to renal artery distance were predictors of
migration, whereas shorter neck length approached but did not reach statistical significance.
Conclusions: Patients who have unfavorable aneurysm neck anatomy experience significantly higher migration, device-
related complication, and secondary intervention rates. However, there was no incidence of open conversion, rupture, or
abdominal aortic aneurysm–related death, thereby supporting the AneuRx device as a feasible alternative to open repair
even in patients with challenging neck characteristics. Enhanced surveillance should be used in these high-risk patients.
(J Vasc Surg 2006;44:932-7.)Endovascular repair of infrarenal abdominal aortic an-
eurysms (EVAR) has become a generally accepted alterna-
tive to open surgery for select patients; it has been shown in
randomized trials to be effective in reducing both morbid-
ity and mortality.1-3 Although it exhibits excellent short-
term results, concern has been raised regarding its long-
term durability. Device failures have included endoleak,
modular component separation, aneurysm enlargement,
stent or hook fractures, and migration. The caudal move-
ment of the proximal graft has been associated with proxi-
mal endoleak, aneurysmal enlargement, and the cataclysmic
occurrence of late aneurysm rupture.4,5 Such device migra-
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932tion has been seen with all currently available devices,
including the AneuRx (Medtronic/AVE Inc, Santa Rosa,
Calif) bifurcated stent graft.6-13
The incidence of AneuRx endograft migration with
early and mid-term follow-up has varied, ranging from 6%
to 7% at 1 year to 27% to 42% at 3 years.6,7,13 Data from the
multicenter AneuRx clinical trial revealed a 3-year Kaplan-
Meier migration rate of 19%.13 At first glance, these mid-
term results are alarming. However, migration is generally
believed to be a late-occurring event, and most studies have
relatively few patients with long-term follow-up, as well as
variability in measurements and definition.
Frequently, clinicians are facedwith patients who are poor
operative candidates and possess aneurysms that do not com-
ply with the proposed anatomic conditions for EVAR. The
objective of this studywas to establish the effect of challenging
neck anatomy on the mid-term incidence of migration by
using the AneuRx bifurcated device in patients treated after
Food and Drug Administration approval and to identify the
predictive factors for device migration.
METHODS
Prospectively maintained databases at the University of
North Carolina (UNC) and Washington University (WU)
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n  365) who underwent EVAR with the AneuRx bifur-
cated stent graft. Because mid- and long-term migration
rates were of primary interest, patients with at least 30
months of follow-up (range, 30-55 months) were identi-
fied and underwent further assessment of migration (UNC,
n 25;WU, n 59). The period of initial EVAR extended
from October 1999 to March 2001, occurring in the first
18 months after Food and Drug Administration approval,
and included only patients treated after commercial avail-
ability of the AneuRx device. No patient was treated as part
of a clinical trial. Institutional review board approval was
obtained at each institution.
Patients were evaluated with preoperative contrast-
enhanced computed tomography (CT) imaging with
3-mm reconstructions. Preoperative imaging was not avail-
able for review for 4 patients (4.8%). In these cases, the
preimplantation intraoperative angiogram was used to es-
timate neck length angle and diameter, and the 1-month
postoperative CT scan was used to determine all other
measurements. Patients were followed up after surgery with
scheduled physical examinations, multiple-view abdominal
radiographs, and CT scans at 1, 6, and 12 months and
yearly thereafter. Additional imaging was obtained as clin-
ically indicated.
Multiplanar reconstructed axial image sets of the pre-
operative and postoperative CT scans were examined by a
single observer. Orthogonal reconstructions that were per-
pendicular to the flow axis, not to the patient, were per-
formed on a workstation. The level of the inferior aspect of
the most caudal patent renal artery was marked. Next, the
most cephalad level at which a complete ring of the AneuRx
device could be visualized wasmarked. The extent of caudal
device migration was based on these measurements. Using
similar multiplanar reconstructions, additional measure-
ments were obtained, including neck length, neck diame-
ter, maximal aneurysm diameter, terminal aorta diameter,
neck-body angle, the extent of neck thrombus and calcifi-
cation, and the presence of endoleak.
All diameter measurements were taken from adventitia
to adventitia. Neck length was measured as the distance
from the most caudal renal artery to the point of initial
aneurysmal dilation. Neck angle was defined by the angle
formed between the flow axes of the neck and body of the
aneurysm.
A minimum of three CT scans were analyzed for each
patient, including the preoperative, 1-month postopera-
tive, and most recent scan. If a patient required a secondary
intervention, the CT scan before the intervention was also
examined. In patients exhibiting device migration, the pre-
ceding CT scans were examined to determine the earliest
evidence of migration. Medical records were reviewed to
identify the presence or absence of potential risk factors,
including age, sex, diabetes mellitus, hypertension, coro-
nary artery disease, smoking history, chronic obstructive
pulmonary disease, chronic renal insufficiency, and use of
-blockers.Freedom from migration over time was expressed as
Kaplan-Meier life-table analysis by using the log-rank test
to determine significance. Bivariate analysis was completed
to study the relationship betweenmigration and the follow-
ing variables: age, sex, diabetes mellitus, hypertension,
coronary artery disease, smoking, chronic obstructive pul-
monary disease, renal insufficiency (RI), preoperative use of
-blockers, aneurysm size, percentage oversizing, neck di-
ameter, neck length, neck angle, and graft deployment
distance from the most caudal renal artery. The 2 test was
used for categorical variables, and the t test was used for
continuous variables. Multivariate analysis, controlling for
each of the possible confounding variables, was also con-
ducted by using both the Cox regression model and the
logistic regression model. A P value .05 was considered
significant. Data are presented as mean SE. Statistical anal-
ysis was conducted with SAS software (SAS Institute Inc,
Cary, NC).
Definition of migration. Migration was defined with
radiographic and clinical parameters as suggested by the
Society for Vascular Surgery/American Association for
Vascular Surgery document on endovascular reporting
standards.14 Migration was therefore defined as device
movement of greater than 10 mm or movement of 10 mm
or less resulting in a secondary intervention or producing
symptoms. Measurements were calculated according to the
methods described previously.
Instructions for use. The commercially available AneuRx
device has been previously described and consists of a mod-
ular system constructed from self-expanding nickel-titanium
(nitinol) alloy stent rings and woven polyester graft tubes.
Initially, proximal neck criteria consisted of a neck length
greater than 1 cm, neck diameter between 17 and 25 mm,
and greater than 10% oversizing.
As of October 2002, the criteria have been revised and
entail at least a 15-mm aortic neck length and oversizing
between 10% and 20%. Additional requirements are a neck
angle of less than 45° and at least a 2.5-cm distal landing
zone.
RESULTS
Eighty-four patients with follow-up of more than 30
months were studied, consisting of 71 men (84%) and 13
women (15%), with a mean age of 73.1  1.1 years and a
mean average aneurysm size of 5.7  1.2 cm (range,
4.4-10.2 cm). The patient risk factors are summarized in
Table I. Aneurysm characteristics are displayed in Table II.
The overall average neck length was 25.6  1.1 mm;
nonmigrators had an average neck length of 26.7  1.2
mm, whereas the average neck length in migrators was
20.5  3.0 mm. The mean neck angle was 26.5°  2.6°
(nonmigrators, 24.1°  2.8°; migrators, 39.5°  6.9°).
Devices were inserted at a mean distance of 3.4  0.5 mm
below the renal arteries (nonmigrators, 2.8  0.5 mm;
migrators, 6.5  1.9 mm).
Upon retrospective review, 70% of the patients (n 
59) met all inclusion criteria for neck anatomy (length,
angle, diameter, and quality) as defined by the revised
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and are referred to as those with favorable neck anatomy
(FNA). The remaining 30% (n  25) had neck charac-
teristics that fell outside of the revised IFU guidelines and
are referred to as those with unfavorable neck anatomy
(UFNA). Thirteen of these patients had a neck-body angle
between 45° and 60°, whereas 6 patients had a neck-body
angle greater than 60°. Four patients had a neck length
between 10 and 15 mm, whereas two patients’ necks were
less than 10 mm. Two patients had endograft oversizing
less than 10%. Distal attachment zone characteristics were
not analyzed. Overall, late graft-related complications oc-
curred in 38% of patients (FNA, 27%; UFNA, 64%; P 
.003; relative risk, 1.7). Complications included endoleak
of any type (n  24; 29%), migration (n  14; 17%), and
component separation (n 3; 4%). There was no incidence
of rupture or aneurysm-related death.
The incidence of type Ia endoleak was 16% (4/25) in
UFNA patients and 5% (3/54) in FNA patients. All were
successfully repaired with placement of a proximal cuff, and
all but 1 patient (6/7) exhibited concomitant migration.
Migration. The mean follow-up time was 40.3
months (range, 30-55months). Life-table analysis for FNA
patients revealed a migration rate of 0% and 6.1% at 2 and 4
years, respectively (Fig 1). For UFNA patients, the migra-
tion rate was 24.0% and 42.1% at 2 and 4 years, respectively.
With use of the log-rank test for comparison, this reached
statistical significance (P  .0001). The overall (FNA and
UFNA) migration rate was 7.1%, 17.1%, and 17.1% at 2, 3,
and 4 years, respectively (Fig 2). Migration in the FNA
subset occurred in 4 (6.8%) of 59 patients. Ten (40%) of the
25 patients with challenging neck anatomy (UFNA) expe-
rienced a migration. Among the 14migrators (FNA, n 4;
UFNA, n 10), 1 patient had movement less than 10 mm
with a secondary intervention. The relative risk of migra-
tion for UFNA patients was 2.5 compared with FNA
Table I. Patient demographics
Variable
Migrators
(n  14)
Nonmigrators
(n  70) P value
Mean age (y) 72.4  2.1 73.3  0.8 NS
Male 11 (79%) 59 (84%) NS
Female 3 (21%) 11 (16%) NS
DM 2 (14%) 10 (14%) NS
HTN 9 (64%) 38 (54%) NS
CAD* 7 (50%) 41 (59%) NS
COPD 3 (21%) 11 (16%) NS
Renal insufficiency† 0 5 (7%) NS
Beta blockade 1 (7%) 7 (10%) NS
Smoker 8 (57%) 49 (70%) NS
UFNA 10 (71%) 17 (24%) .0003
NS, Not significant; UFNA, unfavorable neck anatomy; DM, diabetes
mellitus;HTN, hypertension;CAD, coronary artery disease;COPD, chronic
obstructive pulmonary disease.
*Previous myocardial infarction, angina, or electrocardiogram evidence of
ischemia.
†Preoperative serum creatinine 1.5 mg/Dl or on dialysis.patients (P  .0003).Bivariate analysis of possible risk factors associated with
migration was performed by using the 2 and t-test meth-
ods. Neck-body angle (P  .04), distance of initial place-
ment from the most caudal renal artery (P  .01), and
overall compliance with revised IFU recommendations
(P .0003) were found to influence migration. Because of
the possible confounding nature of several risk factors,
multivariate analysis was implemented by using both Cox
regression and logistic regression models. The results were
similar to those with bivariate analysis. Shorter neck length
approached but did not reach statistical significance for
predicting migration with multivariate analysis (P .053).
Migration did not seem to be influenced by initial aneurys-
mal diameter, percentage oversizing, or neck diameter. No
other patient demographic variable, such as age, -blockade,
medical history, or social history, influenced the risk of migra-
tion.
We then studied the effect of neck-body angle on
migration. Those with a neck-body angle greater than 45°
had a 4 times greater risk of migration than those with an
angle less than 45°. It is interesting to note that when 60°
was used, the odds ratio was only 3.75.
Secondary interventions. The overall secondary in-
vention rate was 26% (FNA, 15%; UFNA, 52%; P .0009;
relative risk, 2.0). Interventions included embolization
(n  6) for type II endoleak, extension cuffs (n  5) for
type Ib endoleak, interposition cuffs (n  3) for type III
endoleak and component separation, and proximal cuffs
(n  12) for type Ia endoleak and migration.
Ten patients underwent successful secondary interven-
tions due to migration (71%). Clinical conditions associated
with migration included type I endoleak (n 7) and enlarg-
ing aneurysm sac (n 4). EVAR consisting of placement of a
proximal cuff was successful in all patients (10/10). Therewas
no conversion to open repair. Those patients who were left
untreated (n  4) have had no adverse consequences and
continue to undergo vigilant surveillance.
DISCUSSION
Reports of the migration of aortic endografts have
raised concern over their long-term durability. Relatively
high rates of migration for the AneuRx device have been
described previously. Cao et al6 reported 113 patients with
a minimum of 24months of follow-up after EVARwith the
AneuRx device. Of these 113 patients, 17 hadmovement of
greater than 10 mm. The probability of migration by
life-table analysis was 20% at 24 months and 27% at 36
months, which is noticeably higher than our results. Of the
patients who had migration, 47% underwent secondary pro-
cedures, and two patients had open conversion. Through
surveillance and early intervention, rupture and abdominal
aortic aneurysm (AAA)-related deaths were avoided.
A higher migration rate was reported by Conners et al,7
who analyzed 91 patients after AneuRx implantation and
used movement of 5 mm or more to define device migra-
tion. Their migration rates were 20.4%, 42.1%, and 66.7%
at 2, 3, and 4 years after implantation, respectively. How-
ever, few patients were available for 3- and 4-year follow-up
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threshold for device migration may increase the number of
false-positive results, taking into consideration the margin
of error when examining 2.5- to 3-mm-slice axial CT scans.
Most recently, Zarins et al13 reviewed 1119 patients
who were enrolled in the multicenter AneuRx clinical trial.
Stent-graft migration was reported in 94 patients. Kaplan-
Meier estimates of migration rates were 7% at 2 years and
19% at 3 years. Only 8% of patients were at risk at the end of
the 3-year interval. Twenty-three (24%) of 94 patients with
migration underwent secondary intervention. One patient
experienced aneurysm rupture associated with graft migra-
tion (successful open repair), and there were no aneurysm-
related deaths.
In this study, all 84 patients had follow-up of at least 30
months, with a mean follow-up time of 40.3 months.
Life-table analysis reveals relatively low migration rates of
0%, 6.1%, and 6.1% at 2, 3, and 4 years, respectively, when
the revised IFU guidelines are followed. These results,
although they represent a subset of patients, are lower than
Table II. Patient characteristics (migrators vs nonmigrato
Variable
All patients
(n  84)
Aneurysm diameter (mm) 56.6  1.2
Male:female 6.6:1
Neck length (mm) 25.6  1.1
Neck diameter (mm) 23.4  2.4
Neck angle (°) 26.5  2.6
% Oversizing 11.6  1.2
Initial distance to renal artery (mm) 3.4  0.5
Type Ia endoleak 7 (8%)
Any endoleak 24 (29%)
NS, Not significant.
Data are mean  SE unless otherwise noted.
Fig 1. Freedom from migration by Kaplan-Meier analysis for
those with favorable neck anatomy (FNA) and unfavorable neck
anatomy (UFNA).those previously published. Not surprisingly, patients withneck anatomy that did not comply with current IFU guide-
lines had much more frequent migration rates of 24%, 42%,
and 42% at 2, 3, and 4 years, respectively. Overall migration
rates were 7.1%, 17.1%, and 17.1%, at 2, 3, and 4 years, with
18 (21%) patients remaining at risk after 48 months. These
overall results are similar to those reported by Zarins et al.13
These data reinforce the importance of patient selection in
patients undergoing EVAR with the AneuRx stent graft.
Of additional note, these reported migration rates are
all accompanied by a notable low incidence of rupture and
AAA-related deaths. Even when examining implantation of
devices into aneurysm necks that did not meet recom-
mended criteria, the results indicate safety, because these
patients have avoided aneurysm rupture by undergoing
secondary procedures and placement of aortic cuffs and
transrenal components to rectify their potential problems.
In our series of patients with challenging neck anatomy, no
patient experienced rupture, AAA-related death, or open
conversion. All necessary interventions were performed via
an endovascular approach. EVAR should therefore not be
discounted in patients with comorbidities that prohibit
open operation even when their neck anatomy does not fall
y multivariate analysis
Migrators
(n  14)
Nonmigrators
(n  70) P value
55.9  5.3 56.8  1.3 NS
3.7:1 7.8:1 NS
20.5  3.0 26.7  1.2 .053
23.2  6.7 23.5  2.6 NS
39.5  6.9 24.1  2.8 .025
10.3  2.4 11.9  1.3 NS
6.5  1.9 2.8  0.5 .011
6 (43%) 1 (1.4%) .0001
6 (43%) 18 (26%) NS
Fig 2. Freedom from migration by Kaplan-Meier analysis for all
patients.rs) bwithin strict IFU guidelines. At the time of their treatment,
; UFN
an.
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these patients could now be treated with alternative de-
vices.
Previous articles implicate various factors as influencing
device migration.8,11,15-17 Cao et al6 found an initial aortic
neck diameter of 25 mm or more, a preoperative AAA size
of greater than 55 mm, and aortic neck enlargement of
greater than 10% to be risk factors for migration. Conners
et al7 demonstrated a trend toward greater endograft over-
sizing in migrators and also found that aortic neck dilata-
tion was a predictor of migration; however, neck angle, size
of the AAA, and initial neck diameter were not. Finally,
Zarins et al13 reported that the proximal fixation length and
the renal artery to stent graft distance were significant in
device migration. Our data support the importance of
neck-body angulation and the initial distance from the
device to the renal arteries. In our study, neck length
approached, but did not achieve, statistical significance. We
did not identify initial neck or aneurysmal diameter or
percentage oversizing as influencing migration. Of note,
the degree of oversizing was not excessive (11.6% 
10.6%).
In this study, several migrators (29%) did not undergo
secondary interventions because of physician discretion or
patient preference. They were closely followed up clinically
and radiographically because of shrinking aneurysm size
and/or a long aneurysm neck providing for a maintained
zone of proximal fixation and sealing. As shown in Table II,
all other patients (71%) successfully received a proximal
aortic cuff, with one patient requiring an embolization of a
type II endoleak. Cases with concomitant type I endoleak
(n  6) were repaired. No patient required open conver-
sion. Our secondary intervention rate is greater than that
reported in other studies. In the AneuRx clinical trial, only
32% of patients with migration underwent treatment. Cao
et al6 repaired 8 (47%) of 17 migrators: 6 patients were
treated with placement of a proximal cuff, and 2 patients
Table III. Patients with migration: timing of migration is
Patient No. Timing of migration (mo) Migration (m
1 1 10
2 12 12
3 12 10
4 14 15
5 22 14
6 23 10
7 30 22
8 30 6
9 33 15
10 35 18
11 36 10
12 36 11
13 36 15
14 49 18
I, Type I endoleak; II, type II endoleak; AE, aneurysm expansion; N, none
*Migration discovered at the 1-month follow-up computed tomographic scunderwent late conversion to open repair. Similarly, Con-ners et al7 treated 5 (33%) of 15 patients with device
migration, all with placement of proximal aortic cuffs. This
variation may be explained in part by the diversity in defin-
ing migration or the distribution of adverse neck character-
istics (Table III).
Although demonstrating encouraging success rates,
the durability of these secondary procedures is not well
documented. Component separation or continued migra-
tion could still potentially occur. Therefore, patients expe-
riencing device migration, including those repaired with
secondary procedures, should undergo enhanced surveil-
lance.
CONCLUSION
In conclusion, the AneuRx bifurcated device under the
revised instructions for use exhibits a low mid-term migra-
tion rate. Patients who have unfavorable aneurysm neck
anatomy experience significantly higher migration, device-
related complication, and secondary intervention rates.
However, there was no incidence of open conversion,
rupture, or AAA-related death, thereby supporting the use
of the AneuRx device as a feasible alternative to open repair
even in those patients with challenging neck characteristics.
Enhanced surveillance should be used in these high-risk
patients.
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Appropriate case selection is a critical step in securing good
long-term outcomes with endovascular repair for abdominal aortic
aneurysm disease. Many reports have documented a relatively high
migration rate associated with AneuRx stent grafts, with predictive
factors mostly related to aneurysm neck anatomy. The current
manuscript confirms the strong association between unsatisfactory
aneurysm neck anatomy and a high risk ofmigration of the AneuRx
device. Neck angulation was the most commonly noted unfavor-
able feature and found to be highly predictive of migration risk.
The results would support a word of caution against using the
AneuRx device in patients with unsuitable necks, especially those
with a significant angulation of the neck to the aneurysm body.
One may quite reasonably disagree with the conclusion of the
authors that the data support “the use of the AneuRx device as a
feasible alternative to open repair even in those patients with
challenging neck characteristics.” A graft-related complication rate
of 64% in this patient subgroup can hardly justify this conclusion.
Open repair is not the only other option, either. The perfor-
mance of endografts clearly differs in certain challenging anatomic
situations and some designs, like the Ancure device, have beenOther currently available devices, with active fixation or more
flexible construction, can still be used in this situation with more
acceptable results. The lack of ruptures or aneurysm-related deaths
in a selected group representing 14% of the total experience is
certainly not convincing enough. A very high reintervention rate of
52% and increased surveillance and heightened concernmay be too
high a price to pay for using AneuRx in these cases.
The data presented here also serve to remind us that unsatisfac-
tory outcomes obtained under certain adverse conditions should not
be used to characterize the performance of a device in all situations.
A relatively low migration risk of 6% at 4 years in patients with
favorable neck anatomy can be viewed as reassurance that accept-
able results can be expected by using the AneuRx device in patients
who fit the revised instructions for use. Appropriate case selection
would thus allow the use of the AneuRx device safely.
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